Jamjoom Pharmaceuticals Factory (4015.SR) Earnings Analysis
Jamjoom Pharmaceuticals Factory (4015.SR) next reports earnings on 2026-10-27. It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 21.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4015.SR next report earnings?
| Next earnings date | 2026-10-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
4015.SR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 2.4 SAR | n/a | n/a | n/a |
| 2025-10-23 | 1.52 SAR | 1.52 SAR | 0% | Beat |
| 2025-07-24 | 1.89 SAR | 1.89 SAR | 0% | Beat |
| 2025-04-30 | 2.24 SAR | n/a | n/a | n/a |
| 2024-10-27 | 1.36 SAR | n/a | n/a | n/a |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
4015.SR valuation and analyst view
| Trailing P/E | 21.51 |
|---|---|
| Trailing EPS | 6.777 SAR |
| Price / book | 5.94 |
| Dividend yield | 2.73% |
| Market cap | 10.26B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jamjoom Pharmaceuticals Factory (4015.SR)'s next earnings date?
Jamjoom Pharmaceuticals Factory is next scheduled to report on 2026-10-27.
Did 4015.SR beat earnings last quarter?
Consensus estimate data was not available for 4015.SR's 2026-04-23 report.
What is 4015.SR's earnings track record?
Over the last 2 reported quarters with consensus data, 4015.SR beat estimates 2 times (100%).
What is 4015.SR's current P/E ratio and EPS?
4015.SR trades at a trailing P/E of 21.51 on trailing EPS of 6.777283828900811 SAR.
What do analysts rate 4015.SR?
4015.SR has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.